Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Microfluidics-based devices: New tools for studying cancer and cancer stem cell migration.

Huang Y, Agrawal B, Sun D, Kuo JS, Williams JC.

Biomicrofluidics. 2011 Mar 30;5(1):13412. doi: 10.1063/1.3555195.

2.

Study of Na+/H+ exchange-mediated pHi regulations in neuronal soma and neurites in compartmentalized microfluidic devices.

Vitzthum L, Chen X, Kintner DB, Huang Y, Chiu SY, Williams J, Sun D.

Integr Biol (Camb). 2010 Jan;2(1):58-64. doi: 10.1039/b918440f. Epub 2009 Dec 14.

3.

A hierarchy of self-renewing tumor-initiating cell types in glioblastoma.

Chen R, Nishimura MC, Bumbaca SM, Kharbanda S, Forrest WF, Kasman IM, Greve JM, Soriano RH, Gilmour LL, Rivers CS, Modrusan Z, Nacu S, Guerrero S, Edgar KA, Wallin JJ, Lamszus K, Westphal M, Heim S, James CD, VandenBerg SR, Costello JF, Moorefield S, Cowdrey CJ, Prados M, Phillips HS.

Cancer Cell. 2010 Apr 13;17(4):362-75. doi: 10.1016/j.ccr.2009.12.049.

4.

Impact of tumor cell cytoskeleton organization on invasiveness and migration: a microchannel-based approach.

Rolli CG, Seufferlein T, Kemkemer R, Spatz JP.

PLoS One. 2010 Jan 15;5(1):e8726. doi: 10.1371/journal.pone.0008726.

5.

Spontaneous migration of cancer cells under conditions of mechanical confinement.

Irimia D, Toner M.

Integr Biol (Camb). 2009 Sep;1(8-9):506-12. doi: 10.1039/b908595e. Epub 2009 Jul 16.

6.

Heterogeneity in cancer: cancer stem cells versus clonal evolution.

Shackleton M, Quintana E, Fearon ER, Morrison SJ.

Cell. 2009 Sep 4;138(5):822-9. doi: 10.1016/j.cell.2009.08.017.

7.

Biological implications of polydimethylsiloxane-based microfluidic cell culture.

Regehr KJ, Domenech M, Koepsel JT, Carver KC, Ellison-Zelski SJ, Murphy WL, Schuler LA, Alarid ET, Beebe DJ.

Lab Chip. 2009 Aug 7;9(15):2132-9. doi: 10.1039/b903043c. Epub 2009 Jun 4. Review.

8.

Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens.

Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, Russell R, Bayani J, Head R, Lee M, Bernstein M, Squire JA, Smith A, Dirks P.

Cell Stem Cell. 2009 Jun 5;4(6):568-80. doi: 10.1016/j.stem.2009.03.014.

9.

Cell migration into scaffolds under co-culture conditions in a microfluidic platform.

Chung S, Sudo R, Mack PJ, Wan CR, Vickerman V, Kamm RD.

Lab Chip. 2009 Jan 21;9(2):269-75. doi: 10.1039/b807585a. Epub 2008 Oct 31.

PMID:
19107284
10.

Activity-dependent dynamic microtubule invasion of dendritic spines.

Hu X, Viesselmann C, Nam S, Merriam E, Dent EW.

J Neurosci. 2008 Dec 3;28(49):13094-105. doi: 10.1523/JNEUROSCI.3074-08.2008.

11.

Filopodia are required for cortical neurite initiation.

Dent EW, Kwiatkowski AV, Mebane LM, Philippar U, Barzik M, Rubinson DA, Gupton S, Van Veen JE, Furman C, Zhang J, Alberts AS, Mori S, Gertler FB.

Nat Cell Biol. 2007 Dec;9(12):1347-59. Epub 2007 Nov 18.

PMID:
18026093
12.

Developmental signaling pathways in brain tumor-derived stem-like cells.

Clark PA, Treisman DM, Ebben J, Kuo JS.

Dev Dyn. 2007 Dec;236(12):3297-308. Review.

13.

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis.

Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA.

Nature. 2007 Oct 4;449(7162):557-63.

PMID:
17914389
14.

Microfluidic devices for culturing primary mammalian neurons at low densities.

Millet LJ, Stewart ME, Sweedler JV, Nuzzo RG, Gillette MU.

Lab Chip. 2007 Aug;7(8):987-94. Epub 2007 Jun 28.

PMID:
17653340
15.

The biology of cancer stem cells.

Lobo NA, Shimono Y, Qian D, Clarke MF.

Annu Rev Cell Dev Biol. 2007;23:675-99. Review.

PMID:
17645413
16.

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM.

Cancer Res. 2006 Oct 1;66(19):9339-44. Epub 2006 Sep 21. No abstract available.

17.

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.

Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, Park JK, Fine HA.

Cancer Cell. 2006 May;9(5):391-403.

18.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group.

N Engl J Med. 2005 Mar 10;352(10):987-96.

19.

Mechanisms of cancer cell invasion.

Sahai E.

Curr Opin Genet Dev. 2005 Feb;15(1):87-96. Review.

PMID:
15661538
20.

Identification of human brain tumour initiating cells.

Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB.

Nature. 2004 Nov 18;432(7015):396-401.

Supplemental Content

Support Center